BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 16380548)

  • 1. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.
    Takahashi H; Takeishi Y; Seidler T; Arimoto T; Akiyama H; Hozumi Y; Koyama Y; Shishido T; Tsunoda Y; Niizeki T; Nozaki N; Abe J; Hasenfuss G; Goto K; Kubota I
    Circulation; 2005 Mar; 111(12):1510-6. PubMed ID: 15781737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diacylglycerol kinase in cellular regulatory processes: a new regulator for cardiomyocyte hypertrophy.
    Takeishi Y; Goto K; Kubota I
    Pharmacol Ther; 2007 Sep; 115(3):352-9. PubMed ID: 17659347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
    Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol kinase zeta rescues G alpha q-induced heart failure in transgenic mice.
    Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Koyama Y; Goto K; Mende U; Kubota I
    Circ J; 2008 Feb; 72(2):309-17. PubMed ID: 18219172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy.
    Harada M; Takeishi Y; Arimoto T; Niizeki T; Kitahara T; Goto K; Walsh RA; Kubota I
    Circ J; 2007 Feb; 71(2):276-82. PubMed ID: 17251681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
    Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
    Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacylglycerol kinase zeta inhibits G(alpha)q-induced atrial remodeling in transgenic mice.
    Hirose M; Takeishi Y; Niizeki T; Shimojo H; Nakada T; Kubota I; Nakayama J; Mende U; Yamada M
    Heart Rhythm; 2009 Jan; 6(1):78-84. PubMed ID: 19121805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-proteins in growth and apoptosis: lessons from the heart.
    Adams JW; Brown JH
    Oncogene; 2001 Mar; 20(13):1626-34. PubMed ID: 11313910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
    Chu CH; Tzang BS; Chen LM; Kuo CH; Cheng YC; Chen LY; Tsai FJ; Tsai CH; Kuo WW; Huang CY
    J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol kinase ΞΆ inhibits ventricular tachyarrhythmias in a mouse model of heart failure.
    Hirose M; Takeishi Y; Niizeki T; Nakada T; Shimojo H; Kashihara T; Horiuchi-Hirose M; Kubota I; Mende U; Yamada M
    Circ J; 2011; 75(10):2333-42. PubMed ID: 21778596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of diacylglycerol kinase zeta with protein kinase C alpha: spatial regulation of diacylglycerol signaling.
    Luo B; Prescott SM; Topham MK
    J Cell Biol; 2003 Mar; 160(6):929-37. PubMed ID: 12629049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
    J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.